BIOPLUS ACQUISITION CORP - CLASS A ORD SHS (BIOS)

CUSIP: G11217117

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / CLASS A ORD SHS
Total 13F shares
12,479,806
Share change
+70,558
Total reported value
$135,176,980
Price per share
$10.84
Number of holders
30
Value change
+$936,363
Number of buys
8
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP G11217117?
CUSIP G11217117 identifies BIOS - BIOPLUS ACQUISITION CORP - CLASS A ORD SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIOPLUS ACQUISITION CORP - CLASS A ORD SHS (BIOS) as of Q3 2023

As of 30 Sep 2023, BIOPLUS ACQUISITION CORP - CLASS A ORD SHS (BIOS) was held by 30 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,479,806 shares. The largest 10 holders included Westchester Capital Management, LLC, BERKLEY W R CORP, First Trust Capital Management L.P., Linden Advisors LP, Radcliffe Capital Management, L.P., COWEN AND COMPANY, LLC, MIZUHO SECURITIES USA LLC, WOLVERINE ASSET MANAGEMENT LLC, AQR Arbitrage LLC, and UBS OCONNOR LLC. This page lists 30 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.